Navigation Links
Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution
Date:5/8/2009

Ravensburg, Germany, May 8, 2009 / b3c newswire / - West (NYSE: WST), the world’s premier manufacturer of components and systems for injectable drug delivery, and Vetter, a worldwide leading independent specialist in the contract manufacturing of prefilled application systems, have introduced a ready-to-use, WFI prefilled syringe for reconstituting lyophilized drug products.

“The Vetter/West WFI syringe combines the best of pharmaceutical components in a drug administration system that we believe customers will embrace,” said Mike Schaefers, Vice President, Marketing, Europe, West. “This system can be applied to our customers’ high-value pharmaceutical and biopharmaceutical drug products.”
“This system unites two of the world’s leaders in drug administration systems and pharmaceutical processing,” said Oskar Gold, Vice President, Key Account Management, Vetter. “We are pleased that we can offer customers a world-class prefilled syringe system.”

The syringe features a plunger with West’s FluroTec® barrier film and Vetter’s V-OVS® tamper-evident closure, which includes a West tip cap. The film, developed by West’s partner, Daikyo Seiko, Ltd., provides an effective barrier against organic and inorganic extractables, which helps maintain the purity of the diluent.

The V-OVS® closure system is designed to give a prefilled syringe system effective protection features. It consists of a tip cap, a Vetter Luer Lock and a tamper-evident seal. The components are pre-assembled as a single part, which is mounted on the syringe barrel with a Luer-cone and Luer-groove. The integrity of the syringe system is maintained if the seal has not been broken.  The syringes are available with fill volumes between 0.5mL and 3.0mL. The glass syringe barrels are treated with baked silicone for lubricity and are 100 percent visually inspected to provide highest quality levels.

Customers will have packaging options, including individual blister packaging.
Vetter fills and terminally sterilizes the syringe at its facility in Langenargen, Germany. The syringes are supplied with regulatory documentation to meet requirements of markets in Europe, Japan, North America and numerous other countries.

About West
West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.

About Vetter
Vetter is an independent international specialist in the production of aseptically pre-filled injection systems, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. With about 1,900 employees worldwide, Vetter holds about 140 patents and has longstanding experience in handling client products and processes approved by the FDA, EMEA and other authorities.

FluroTec® is a registered trademark of West Pharmaceutical Services, Inc. in the United States and other jurisdictions. 
FluroTec technology is licensed from Daikyo Seiko, Ltd. 
Vetter and V-OVS® are registered trademarks of Vetter Pharma-Fertigung GmbH& Co.KG in Germany, the United States and other jurisdictions. 
MixJect® is a registered trademark of Medimop Medical Projects Inc.


For more information contact 
Vetter Pharma International GmbH
Oskar Gold
Eywiesenstrasse 5
88212 Ravensburg
Germany
phone: +49-(0)751-3700 - 0
fax: +49-(0)751-3700 - 40 00
e-mail: info@vetter-pharma.com
www.vetter-pharma.com
'/>"/>

b3c newswire

Related biology news :

1. Improved e-jet printing provides higher resolution and more versatility
2. Canada provides $1.4M for removal of hazardous trees from provincial recreation sites
3. Study involving more than 100 scientists provides new insights on green algae
4. Shell Provides Consumers Gasoline Industrys First Pay By Touch Technology at the Pump
5. Book on little-known species and conservation provides guidance to managers and others
6. HIV isolate from Kenya provides clues for vaccine design
7. Antarctic expedition provides new insights into the role of the Southern Ocean for global climate
8. Mesothelin engineered on virus-like particles provides treatment clues for pancreatic cancer
9. Scripps expedition provides new baseline for coral reef conservation
10. Researcher provides tool to enable determination of age of anchovies with greater precision
11. Research with squirrels provides clues on hormones role in human learning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... , May 16, 2017   Bridge ... health organizations, and MD EMR Systems , ... development partner for GE, have established a partnership ... Portal product and the GE Centricity™ products, including ... EMR. These new integrations will ...
(Date:4/24/2017)... , April 24, 2017 ... and partner with  Identity Strategy Partners, LLP (IdSP) ... "With or without President Trump,s March 6, 2017 ... Terrorist Entry , refugee vetting can be instilled with ... resettlement. (Right now, all refugee applications are suspended ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc., a global expert ... a media edge server, the M820, which features the company,s hybrid ... software provided by Tera Probe, Inc., will be showcased during the ... the NAB show at the Las Vegas ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... BARBARA, CALIFORNIA (PRWEB) , ... October 10, 2017 ... ... management, technological innovation and business process optimization firm for the life sciences and ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
Breaking Biology Technology: